Covid Pills to Become More Widely Available
The Biden administration on Tuesday is expected to outline plans to make it easier for infected people to get Covid-19 treatments, which some health leaders and patient advocates say are too difficult to obtain despite a federal program to help make them more widely available. The administration has heavily touted vaccines to reduce the risk of serious illness from Covid-19. Officials also have been urging greater use of two pills given they are easy to take at home: Pfizer Inc.’s Paxlovid and Merck & Co.’s and Ridgeback Biotherapeutics LP’s molnupiravir, also known as Lagevrio. Both were cleared for use by the U.S. Food and Drug Administration in December. The authorization of those pills marked a turning point in the treatment of Covid-19 because people can take the therapies at home shortly after they develop symptoms, helping prevent hospitalization.
The Wall Street Journal - April 26, 2022View the full story here: https://www.wsj.com/articles/covid-pills-to-become-more-widely-available-11650963601